Ascendis Pharma has ended internal development of its IL-2 candidate, pivoting away from oncology and calling time on an ...
British broadcaster Sky has unveiled an offer with 20% off its Sky Glass Gen 2 and Sky Glass Air TVs – with built-in ...
MedPage Today on MSN
Safety Data on the Novel Pancreatic Cancer Drug Available by Early Access
Rash, diarrhea, nausea, and other potential side effects to expect ...
Daraxonrasib demonstrated unprecedented survival benefit in Phase 3 RASolute 302 trial in previously treated metastatic pancreatic cancer; ...
As Windows Central reports, the feature maxes out the CPU frequency in a short 1- to 3-second burst when the user performs a ...
Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid ...
WhatsApp has published two new security advisories describing vulnerabilities that were patched earlier this year.
Treatments based on genomic profiling can significantly extend survival for patients with advanced or rare cancer, but only ...
Operator: Good day, and thank you for standing by. Welcome to the OraSure Technologies, Inc. 2026 First Quarter Earnings ...
Nexxen International's growth is driven by exclusive, equity-linked partnerships, especially with the V operating system. See ...
Total Revenues of $610.8 million, Cabozantinib Franchise U.S. Net Product Revenues of $555.0 million -- GAAP Diluted EPS of $0.79, Non-GAAP Diluted EPS of $0.87 -- Announced Additional Stock ...
Little more than 20 years ago, Ryan Silverfield was a failed high school head coach. Now? He's charged with leading an SEC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results